<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The nuclear phosphoprotein p53 is an important regulator of cell proliferation in <z:mpath ids='MPATH_458'>normal</z:mpath> cells </plain></SENT>
<SENT sid="1" pm="."><plain>Interestingly, the gene encoding p53 has usually undergone mutations in a wide range of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> types </plain></SENT>
<SENT sid="2" pm="."><plain>Recent studies of the p53 gene in Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> have demonstrated that mutations are extremely common, and in fact it is rare that both alleles of the p53 gene in these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> are not inactivated by mutation or deletion </plain></SENT>
<SENT sid="3" pm="."><plain>We present here genetic data regarding the status of the p53 gene in the Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line, Raji </plain></SENT>
<SENT sid="4" pm="."><plain>As is typical for this type of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, both alleles have undergone point mutations </plain></SENT>
<SENT sid="5" pm="."><plain>Further, statistical analysis of available data from a large number of Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> indicates an apparent <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific distribution of p53 mutations </plain></SENT>
<SENT sid="6" pm="."><plain>The possibility that specific mutations of the p53 gene may be important for different <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> types is discussed </plain></SENT>
</text></document>